| 000 | 01492 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250510210719.0 | ||
| 264 | 0 | _c19770630 | |
| 008 | 197706s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(77)92279-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHussain, M A | |
| 245 | 0 | 0 |
_aEffect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMay 1977 |
||
| 300 |
_a977-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia, Sideroblastic _xcongenital |
| 650 | 0 | 4 |
_aAscorbic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDeferoxamine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemosiderosis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 |
_aIron _xurine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aSkin |
| 650 | 0 | 4 |
_aThalassemia _xtherapy |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 700 | 1 | _aGreen, N | |
| 700 | 1 | _aFlynn, D M | |
| 700 | 1 | _aHoffbrand, A V | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8019 _gp. 977-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(77)92279-6 _zAvailable from publisher's website |
| 999 |
_c65718 _d65718 |
||